Table 1.

The association of the expression of CD59 with the clinicopathological features from ESCC patients (n = 80)

	CD59		P
	Low level	High level
Age			0.303
<60	24	23
≥60	13	20
Gender			0.363
Male	30	38
Female	7	5
Stage			0.713
I–II	17	18
III–IV	20	25